{
    "clinical_study": {
        "@rank": "3066", 
        "acronym": "FLISH-ILT", 
        "arm_group": [
            {
                "arm_group_label": "levofloxacin", 
                "arm_group_type": "Experimental", 
                "description": "Levofloxacin 500 mg daily for 9 months starting on the waiting list for liver transplant"
            }, 
            {
                "arm_group_label": "Isoniazid", 
                "arm_group_type": "Active Comparator", 
                "description": "Isoniazid 300 mg/day for 9 months beginning after transplantation, when the \"liver function is stable\" and not before 3 months nor after 6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "A multicenter, prospective, non-inferiority, randomized and open clinical trial comparing\n      levofloxacin with isoniazid in the treatment of latent tuberculosis infection in patients\n      eligible for liver transplantation.\n\n      Patients over 18 years of age on the waiting list for liver transplantation.\n\n      Sample size: n=870 patients.\n\n      HYPOTHESIS\n\n      Levofloxacin treatment of latent tuberculosis infection, begun while on the waiting list for\n      liver transplantation, is safer and not less effective than isoniazid treatment begun after\n      transplantation when liver function is stable."
        }, 
        "brief_title": "\"Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients\".", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Latent Tuberculosis Infection", 
            "Infection in Solid Organ Transplant Recipients"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Tuberculosis", 
                "Latent Tuberculosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Primary Objective\n\n        1. To demonstrate that the incidence of tuberculosis in patients with latent tuberculosis\n           infection and treated with levofloxacin is not higher than that observed in patients\n           treated with isoniazid.\n\n           Secondary Objective\n\n        2. To demonstrate that the efficacy of levofloxacin is not limited by adverse effects,\n           paying particular attention to hepatotoxicity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Liver transplantation candidates with age \u2265 18 years, no clinical or radiological evidence\n        of active tuberculosis and negative pregnancy test (if applicable)who must meet one or\n        more of the following criteria:\n\n          -  PPD skin test (initial or after a \"booster effect\") >5 mm. Alternatively, the\n             determination may be made by the interferon gamma (IFN-g) production in\n             PPD-stimulated lymphocytes using the Quantiferon-TB or ELISPOT assays.\n\n          -  Past history of tuberculosis not properly treated.\n\n          -  Past history of contact with a patient with active TB.\n\n          -  Chest x-ray consistent with past untreated TB (apical fibronodular lesions, calcified\n             solitary nodule, calcified lymph nodes or pleural thickening).\n\n        The patient must give their written informed consent.\n\n        Exclusion Criteria:\n\n          -  Lack of consent to participate in the study.\n\n          -  Intolerance or allergy to levofloxacin or to isoniazid.\n\n          -  Documented contact with tuberculosis resistant to levofloxacin or to isoniazid.\n\n          -  Treatment in the previous month with drugs with potential activity against\n             Mycobacterium tuberculosis, (especially quinolones)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "870", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761201", 
            "org_study_id": "FLISH-ILT", 
            "secondary_id": "2010-022302-41"
        }, 
        "intervention": [
            {
                "arm_group_label": "levofloxacin", 
                "description": "Levofloxacin", 
                "intervention_name": "Levofloxacin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Generic name: Levofloxacin", 
                    "ATC Code: J01MA.", 
                    "Pharmaceutical form: Levofloxacin 500 mg film-coated tablets"
                ]
            }, 
            {
                "arm_group_label": "Isoniazid", 
                "description": "300 mg/day for 9 months beginning after transplantation, when the \"liver function is stable\" and not before 3 months nor after 6 months.", 
                "intervention_name": "Isoniazid", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Generic name: Isoniazid.", 
                    "ATC Code: J04AC", 
                    "Pharmaceutical form: tablets."
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Isoniazid", 
                "Ofloxacin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prophylaxis", 
            "Tuberculosis", 
            "Transplant recipients", 
            "Transplant waiting list"
        ], 
        "lastchanged_date": "October 16, 2013", 
        "location": [
            {
                "contact": {
                    "email": "josemariamoren@yahoo.es", 
                    "last_name": "Jose M\u00aa Moreno Planas, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Albacete", 
                        "country": "Spain"
                    }, 
                    "name": "Complejo Hospitalario de Albacete"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Mar\u00eda Moreno Planas, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Agus.mu\u00f1ozsanz@gmail.com", 
                    "last_name": "Agust\u00edn Mu\u00f1oz Sanz, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Badajoz", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Infanta Cristina,"
                }, 
                "investigator": {
                    "last_name": "Agust\u00edn Mu\u00f1oz Sanz, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "olen@ir.vhebron.net", 
                    "last_name": "Oscar Len, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Vall d'Hebron"
                }, 
                "investigator": {
                    "last_name": "Oscar Len, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "amoreno@clinic.ub.es", 
                    "last_name": "Asunci\u00f3n Moreno, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Clinic"
                }, 
                "investigator": {
                    "last_name": "Asunci\u00f3n Moreno, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "josemiguel.montejobaranda@osakidetza.net", 
                    "last_name": "Miguel Montejo, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital de Cruces"
                }, 
                "investigator": {
                    "last_name": "Miguel Montejo, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Enrique.miguez.rey@sergas.es", 
                    "last_name": "Enrique Miguez, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Coru\u00f1a", 
                        "country": "Spain"
                    }, 
                    "name": "Complejo Hospitalario Universitario"
                }, 
                "investigator": {
                    "last_name": "Enrique Miguez, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Vidal.elisa@gmail.com", 
                    "last_name": "Elisa Vidal, Md.PhD", 
                    "phone": "+34 011636957"
                }, 
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Reina Sof\u00eda"
                }, 
                "investigator": {
                    "last_name": "Elisa Vidal, Md.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mangel.lopez.sspa@juntadeandalucia.es", 
                    "last_name": "Miguel Angel L\u00f3pez Ruz, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Granada", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital universitario Virgen de las Nieves"
                }, 
                "investigator": {
                    "last_name": "Miguel Angel L\u00f3pez Ruz, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pmunoz@hggm.es", 
                    "last_name": "Patricia Mu\u00f1oz"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Gregorio Mara\u00f1\u00f3n"
                }, 
                "investigator": {
                    "last_name": "Patricia Mu\u00f1oz, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "pmartin.hrc@salud.madrid.org", 
                    "last_name": "Pilar Mart\u00edn D\u00e1vila, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Ram\u00f3n y Cajal"
                }, 
                "investigator": {
                    "last_name": "Pilar Mart\u00edn D\u00e1vila, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rafasjg@yahoo.es", 
                    "last_name": "Rafael san Juan, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital 12 de Octubre"
                }, 
                "investigator": {
                    "last_name": "Rafael San Juan, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "isolina6@hotmail.com", 
                    "last_name": "Isolina Ba\u00f1os P\u00e9rez, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Puerta de Hierro"
                }, 
                "investigator": {
                    "last_name": "Isolina Ba\u00f1os P\u00e9rez, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "joseapons@yahoo.es", 
                    "last_name": "Jos\u00e9 Antonio Pons Mi\u00f1ano, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Murcia", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Virgen de la Arrixaca"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Antonio Pons Mi\u00f1ano, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "juan.rodrigo.sspa@juntadeandalucia.es", 
                    "last_name": "Juan Rodrigo, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00e1laga", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Carlos Haya"
                }, 
                "investigator": {
                    "last_name": "Juan Rodrigo, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "iherrero@unav.es", 
                    "last_name": "Jos\u00e9 Ignacio Herrero Santos, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain"
                    }, 
                    "name": "Cl\u00ednica Universitaria de Navarra"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Ignacio Herrero Santos, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mirfac@humv.es", 
                    "last_name": "Carmen Fari\u00f1as, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Santander", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Marqu\u00e9s de Valdecillas"
                }, 
                "investigator": {
                    "last_name": "Carmen Fari\u00f1as, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mariae.cordero.sspa@juntadeandalucia.es", 
                    "last_name": "Elisa Cordero Mat\u00eda, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seville", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Virgen del Roc\u00edo"
                }, 
                "investigator": {
                    "last_name": "Elisa Cordero Mat\u00eda, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mblanes@ono.com", 
                    "last_name": "Mario Blanes, MD.PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario La Fe"
                }, 
                "investigator": {
                    "last_name": "Mario Blanes, MD.PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "\"A Prospective, Randomized, Comparative Clinical Trial of the Efficacy and Safety of Levofloxacin Versus Isoniazid in the Treatment of Latent Tuberculosis Infection in Liver Transplant Patients\".", 
        "other_outcome": {
            "description": "Drug tolerance will be evaluated by a clinical study interview and periodic analytical determinations which will include levels of transaminases (ALT and AST), alkaline phosphatase and gamma-GT, bilirubin, according to the study visit schedule.\nAll symptoms and laboratory results will be evaluated for severity according to the grading (severity) scale of the National Cancer Institute Common Toxicity Criteria Version 3.0, NCI-CTC-AE v 3.0.", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "18 months"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain", 
                "last_name": "Juli\u00e1n de la Torre Cisneros, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitario 12 de Octubre, Madrid", 
                "last_name": "Jos\u00e9 M. Aguado, MD, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A patient will be considered as having tuberculosis when Mycobacterium tuberculosis is isolated by culture or M. Tuberculosis DNA is isolated from a representative clinical sample, organ fluid or tissue by polymerase chain reaction. Also cases of histopathologically confirmed tuberculosis (caseating granulomas with/without demonstration of acid-alcohol resistant bacillus [BAAR]) and clinically compatible presentation will be accepted. Tuberculosis will be classified as pulmonary (pulmonary parenchymal involvement), extrapulmonary (involvement of different organs to the lung) or disseminated (involvement of at least two non-contiguous organs). Cases where tuberculosis is diagnosed on the basis of clinical and/or radiology suspicion and for whom the corresponding physician has prescribed a specific treatment will not be accepted.", 
            "measure": "Difference in incidence of tuberculosis disease", 
            "safety_issue": "No", 
            "time_frame": "18 months of follow-up"
        }, 
        "reference": [
            {
                "PMID": "19445585", 
                "citation": "Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros JM, Bou G, Mu\u00f1oz P, Ramos A, Gurgui M, Borrell N, Fort\u00fan J, Moreno A, Gavalda J; Spanish Network for Research in Infectious Diseases. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009 Jun 15;48(12):1657-65. doi: 10.1086/599035."
            }, 
            {
                "PMID": "9158022", 
                "citation": "Aguado JM, Herrero JA, Gavald\u00e1 J, Torre-Cisneros J, Blanes M, Ruf\u00ed G, Moreno A, Gurgu\u00ed M, Hayek M, Lumbreras C, Cantarell C. Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation. 1997 May 15;63(9):1278-86. Review. Erratum in: Transplantation 1997 Sep 27;64(6):942."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761201"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of deaths of any cause", 
                "measure": "Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "18 months"
            }, 
            {
                "description": "Occurrence of grade 3 or 4 toxicities according to the grading (severity) scale of the National Cancer Institute Common Toxicity Criteria Version 4.0, NCI-CTC-AE v 4.0.", 
                "measure": "Toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "During all the 18 months of follow-up"
            }, 
            {
                "description": "A new liver transplantation during the follow-up", 
                "measure": "Retransplantation", 
                "safety_issue": "Yes", 
                "time_frame": "18 months"
            }, 
            {
                "description": "Development of advanced graft fibrosis stages 3 and 4", 
                "measure": "Graft dysfunction", 
                "safety_issue": "Yes", 
                "time_frame": "18 months"
            }, 
            {
                "description": "The occurrence of acute rejection or chronic rejection as per conventional definitions during the follow-up.", 
                "measure": "Transplant rejection", 
                "safety_issue": "Yes", 
                "time_frame": "18 months"
            }
        ], 
        "source": "Fundaci\u00f3n P\u00fablica Andaluza para la gesti\u00f3n de la Investigaci\u00f3n en Sevilla", 
        "sponsors": {
            "collaborator": {
                "agency": "Spanish Network for Research in Infectious Diseases", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n P\u00fablica Andaluza para la gesti\u00f3n de la Investigaci\u00f3n en Sevilla", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}